AbCellera Results Presentation Deck
2020 BUSINESS UPDATE. TECHNOLOGY EXPANSION
THE GOAL: TARGET
TO FILL-FINISH
IN ONE YEAR.
Future plans for deepening the tech stack include:
Cell line
development
+
AA
GMP manufacturing facility for
production of biologics for
clinical testing
FINANCIAL POST
Abcellera Receives $126 Million
from the Government of Canada to
Discover Solutions for COVID-19
and Build a Manufacturing Facility
for Antibody Drugs
Ab Cellera
This facility, which is partly funded by a $126M grant by
the Government of Canada, will be the first in Canada
capable of going from a patient sample to manufacturing
antibodies for clinical testing
x
Ab Cellera's world-leading drug discovery technology identifies
antibodies for potential use in drugs to treat and prevent COVID-19
COPYRIGHT ABCELLERA
14View entire presentation